Short Wave hosts Emily Kwong and Regina Barber discuss a paralyzed man that walked once more, a sticker vaccine and the science behind a crop of recent RSV vaccines.
AILSA CHANG, HOST:
Time now for some science information from our pals at NPR’s Short Wave podcast. Emily Kwong and Regina Barber are the hosts, and so they’re right here now for our science roundup. Hey to each of you.
REGINA BARBER, BYLINE: Hey, Ailsa.
EMILY KWONG, BYLINE: Ailsa, hello.
CHANG: So what have you ever obtained for us this week?
BARBER: We’ve picked out three biomedical tales for you.
KWONG: Yeah. One is a couple of new vaccine to guard adults towards respiratory syncytial virus – or RSV. One is a couple of measles sticker vaccine.
CHANG: Sticker?
BARBER: Yeah (laughter).
KWONG: Sticker. And lastly, one is about know-how that is letting a paralyzed man stroll once more.
CHANG: Oh, my God. Where will we even start? Emily, what are we going to begin with?
KWONG: Let’s begin with RSV. You know, for most individuals, it feels just like the frequent chilly, Ailsa, however it could possibly make infants and older individuals actually sick. Complications from RSV, like pneumonia and bronchiolitis, is the No. 1 trigger for hospitalizations in infants. And for adults 65 and older, the CDC – the Centers for Disease Control and Prevention – estimate that RSV results in tens of hundreds of hospitalizations yearly and between 6,000 and 10,000 deaths.
BARBER: Wow.
CHANG: Wow. I had no concept that RSV might be that critical for sure populations. Tell me extra about this new vaccine.
KWONG: Yeah, so RSV researchers have been working for many years on a vaccine, and now there are two on the horizon for older adults. The first, made by GSK, obtained FDA approval final month, and the second, made by Pfizer, was accepted this week. In scientific trials, each seem to considerably scale back RSV-associated decrease respiratory tract illness in older adults. And this comes on the heels of an RSV vaccine for infants that might get really helpful for FDA approval, too. That might occur this summer time.
CHANG: Right. And why have these RSV vaccines taken so lengthy to develop if this has been round for some time – this virus?
KWONG: This is such a superb query. You know, it simply took time to get the science proper – for the vaccine to be secure and efficient. The massive breakthrough got here from a bunch of NIH scientists who mapped the hidden construction of floor proteins. That’s what permits the virus to contaminate human cells.
CHANG: OK.
KWONG: Over a decade in the past, this workforce discovered a strategy to hack the virus, stopping these floor proteins from remodeling in a means that makes them a lock-and-key match for our cells. Here’s lead researcher Barney Graham, who’s now primarily based at Morehouse School of Medicine.
BARNEY GRAHAM: It’s just like the Transformer toys. If what you need is a automotive and what you have got is a robotic, it’s a must to lock the automotive.
CHANG: OK, I like this Transformer analogy, so let me be sure I get it. They have to catch this virus protein earlier than it morphs into its most harmful part and infects you.
KWONG: It is, like, a superhero-stakes state of affairs.
CHANG: (Laughter) OK.
KWONG: Yeah, yeah – one thing like that. Barney, by the best way – he stands to earn capped royalties on the sale of the RSV vaccines utilizing this design.
CHANG: OK, so now that the FDA has accepted these vaccines, when will they really grow to be obtainable?
KWONG: This is the important thing query. So for the vaccine to be pushed to {the marketplace}, the CDC’s Advisory Committee on Immunization Practices – or ACIP – has to advocate it for older adults. They are assembly on June 21 by way of 23 to make that call. So there is a regulatory hurdle, however there’s additionally an uptake hurdle. People may not know concerning the vaccine or not wish to get it or not know the place to get it. Vaccination simply takes buy-in from household docs and internists, and a few well being care suppliers might not assume that RSV is a giant deal for adults and never advise their sufferers to get vaccinated. And if the CDC’s advisory committee would not advocate the RSV vaccine in a number of weeks, insurance coverage will not cowl it, so individuals must pay out of pocket.
CHANG: OK. Now, for our second story, we’ll keep on the subject of vaccines. I wish to get to this sticker vaccine. This is for the measles?
KWONG: Yeah, so it is a scientific trial for the vaccine to guard towards measles and rubella. Both are characterised by fevers and crimson rashes. Measles, particularly, might be actually critical. In 2021, it killed greater than 100,000 individuals worldwide, largely youngsters below 5.
BARBER: Yeah, so well being correspondent Fran Kritz wrote about this vaccine for Goats And Soda, NPR’s world well being and improvement weblog. And she mentioned that the factor that has researchers excited is not the vaccine itself. The vaccine has been round for many years. What researchers are enthusiastic about is the brand new means the vaccine is delivered, which has been in works for greater than twenty years.
CHANG: And let me guess, it is getting delivered by a sticker?
BARBER: Truly – a sticker.
KWONG: Yeah.
CHANG: (Laughter) You simply slap it on?
BARBER: Yeah. It’s only a small, like, white adhesive patch, concerning the measurement of 1 / 4.
CHANG: Wow.
BARBER: And inside a couple of minutes of the patch being gently pressed onto the affected person’s wrist, the vaccine dose is delivered.
CHANG: So it would not harm?
KWONG: It is virtually pain-free. One of the researchers truly in contrast it to the sensation of Velcro in your pores and skin.
CHANG: Cool.
BARBER: And it is hopefully an enormous step in the direction of wider vaccine accessibility, since it is not a needle, and it is a greater possibility for areas the place there’s few well being services and clear water.
KWONG: Yeah. This this uptake query, which we heard about within the earlier story – it is an actual concern with vaccines. The patch additionally would not have to be refrigerated, which many vaccines often do, so there’s extra accessibility there, too.
CHANG: And what concerning the effectiveness right here? Like, this patch that looks like Velcro – it is a sticker. It’s not a shot. Is it as efficient as a shot?
BARBER: Yeah, it’s. It produced the identical type of immune response. Now, this was a small trial – only a couple hundred infants, toddlers and a few adults. So this nonetheless must be examined on a a lot bigger scale after which get authorization from nations’ regulatory companies. So it might be one other 5 to 7 years earlier than we see it getting used, but it surely’s a promising first step.
KWONG: Yeah, it is a massive deal.
CHANG: Fascinating. OK, so final up, Regina, you have got a narrative about an intervention that might assist individuals with paralysis stroll once more – am I clear on this? I imply, it sounds prefer it’s made for a film.
BARBER: Yes. I like motion pictures.
CHANG: (Laughter).
BARBER: Yes. Yes. Over a decade in the past, Gert-Jan Oskam was paralyzed from a biking accident, and that damage interrupted the communication between his mind and spinal twine. And not too long ago, researchers have reconnected them so he can stroll once more.
CHANG: Wow. OK. So how does this know-how work?
BARBER: Yeah. So first, they want to determine what his mind indicators appear like when he is serious about strolling. And they interpret that with one thing referred to as a brain-computer interface. And that is not new know-how. That’s been round for some time to, like, transfer cursors on a display, to regulate small robots by simply considering. And on this case, a mind implant decodes Gert-Jan’s ideas. Then, these ideas are despatched wirelessly to a wearable processor that appears like a backpack, and it detects his intentions to maneuver and interprets these mind indicators into electrical pulses. These pulses are despatched to a different implant that stimulates his spinal twine, permitting him to truly make these actions.
CHANG: And all this occurs in, like, simply cut up seconds?
BARBER: Yes.
CHANG: Wow. OK, so you have talked about elements of this have been completed earlier than. So what is definitely new right here?
BARBER: Yeah. So what’s new right here is how they mix these two recognized applied sciences – of studying the mind’s ideas and utilizing them to stimulate the spinal twine. That’s in accordance with Marco Capogrosso, a spinal twine damage researcher on the University of Pittsburgh. He’s not related to the research, however he’s very impressed on how actual this strolling appears. The affected person might even go up and down ramps, navigate obstacles, go up stairs. And up to now, sufferers have solely been capable of sort of have these uneven steps, and it was laborious for them to maneuver on something that wasn’t flat floor.
CHANG: This is unimaginable. But, wait – this, to date, has simply been examined on this one particular person, proper? Like…
BARBER: Yeah.
CHANG: …So how may this know-how be rolled out extra extensively?
BARBER: So similar reply because the sticker vaccine – Marco says in all probability about 5 to 7 years. More analysis must be completed to see who else this might help – like, degree of damage – be sure it is secure. And it is fairly costly proper now.
CHANG: So cool.
That is Regina Barber and Emily Kwong. They are the hosts of NPR’s science podcast, Short Wave, the place you’ll be able to find out about new discoveries, on a regular basis mysteries and the science behind the headlines.
Emily and Regina, thanks a lot, as at all times.
BARBER: Thank you, Ailsa.
KWONG: Thank you, Ailsa.
(SOUNDBITE OF MUSIC)
Copyright © 2023 NPR. All rights reserved. Visit our web site phrases of use and permissions pages at www.npr.org for additional data.
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content is probably not in its last type and could also be up to date or revised sooner or later. Accuracy and availability might fluctuate. The authoritative report of NPR’s programming is the audio report.